Post-market, Randomized, Controlled, Prospective Study Evaluating Intrathecal Morphine (IT) Versus Conventional Medical Management (CMM) in the Non-cancer, Refractory, Chronic Pain Population (PROSPER)

Conditions:   Chronic Nonmalignant Pain;   Pain, Intractable;   Pain, Chronic Interventions:   Device: Flowonix Prometra® II Programmable Infusion System;   Drug: Opioids, Neuropathic pain medications, antispasmodics, NSAIDS, etc. Sponsors:   Evolve Restorative Center;   Flowonix Medical;   Celéri Health;   Advanced Infusion Solutions Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials